Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Chlorpheniramine / Cytokine Storm / Endothelium / H1 Receptor / Histamine / Inflammation / Long-haul Disease / Mast Cell / Nasal mucosa / Upper Respiratory Tract Posted on: June 25, 2025April 22, 2025

Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor […]